Published in Eur J Clin Pharmacol on March 31, 2011
Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments. Dtsch Arztebl Int (2013) 2.37
Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy. Clin Pharmacokinet (2016) 0.99
Regional and temporal variations in coding of hospital diagnoses referring to upper gastrointestinal and oesophageal bleeding in Germany. BMC Health Serv Res (2011) 0.97
Concurrent use of tramadol and oral vitamin K antagonists and the risk of excessive anticoagulation: a register-based nested case-control study. Eur J Clin Pharmacol (2012) 0.77
Causes and timing of delayed bleeding after oral surgery. Clin Oral Investig (2013) 0.75
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ (2004) 21.39
A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol (2005) 8.77
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
National surveillance of emergency department visits for outpatient adverse drug events. JAMA (2006) 6.24
Systematic overview of warfarin and its drug and food interactions. Arch Intern Med (2005) 5.86
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med (2010) 4.01
Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest (2006) 3.54
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med (1993) 2.70
Major bleeding after hospitalization for deep-venous thrombosis. Am J Med (1999) 2.25
Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol (2009) 2.13
Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ (2008) 2.02
Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ (2007) 2.02
Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf (2006) 2.01
Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol (2010) 1.97
Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med (2005) 1.91
Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study. Arch Intern Med (2010) 1.87
Drug and dietary interactions of the new and emerging oral anticoagulants. Int J Clin Pract (2010) 1.80
Anticoagulation after cardioembolic stroke: to bridge or not to bridge? Arch Neurol (2008) 1.79
Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions. J Manag Care Pharm (2006) 1.63
Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med (2005) 1.56
Effect of oral antiplatelet agents on major bleeding in users of coumarins. Thromb Haemost (2008) 1.48
The safety of levofloxacin in elderly patients on warfarin. Am J Med (2005) 1.43
Interaction between warfarin and levofloxacin: case series. South Med J (2007) 1.40
Risk of major hemorrhage for outpatients treated with warfarin. J Gen Intern Med (1998) 1.36
Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients. Thromb Haemost (2009) 1.34
Clinically important drug interactions with anticoagulants. An update. Clin Pharmacokinet (1996) 1.34
Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding. Clin Pharmacol Ther (2008) 1.30
Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf (2008) 1.28
The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med (2005) 1.24
Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin. Thromb Haemost (2005) 1.23
Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol. Clin Pharmacokinet (2005) 1.18
Incidence and predictors of severe bleeding during warfarin treatment. J Thromb Thrombolysis (2007) 1.09
Main comedications associated with major bleeding during anticoagulant therapy with coumarins. Eur J Clin Pharmacol (2005) 1.09
The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom. Br J Gen Pract (2003) 1.08
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon. Thromb Haemost (2008) 1.06
Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants. Thromb Haemost (2002) 0.99
Concomitant coumarin-NSAID therapy and risk for bleeding. Ann Pharmacother (2003) 0.96
Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany. Eur J Clin Pharmacol (2004) 0.94
Interactions between warfarin and three commonly prescribed fluoroquinolones. Ann Pharmacother (2008) 0.92
Outcomes associated with combined antiplatelet and anticoagulant therapy. Chest (2008) 0.90
Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation. Thromb Haemost (2001) 0.89
Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants. J Thromb Haemost (2007) 0.89
Moxifloxacin-warfarin interaction: a series of five case reports. Ann Pharmacother (2005) 0.89
Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin. Ann Pharmacother (2009) 0.88
Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin Pharmacol Ther (2001) 0.87
Obesity is associated with a slower response to initial phenprocoumon therapy whereas CYP2C9 genotypes are not. Eur J Clin Pharmacol (2006) 0.86
Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro. Eur J Clin Pharmacol (2004) 0.86
Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German database. Pharmacoepidemiol Drug Saf (2010) 0.85
Response to warfarin and other oral anticoagulants: effects of disease states. South Med J (2000) 0.85
Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants. Clin Pharmacol Ther (2002) 0.84
Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction. Pharmacotherapy (2005) 0.83
The interaction of moxifloxacin and warfarin in three elderly patients. Eur J Intern Med (2003) 0.81
Ciprofloxacin-warfarin coagulopathy: a case series. Am J Hematol (2000) 0.75
Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med (2007) 6.23
Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med (2007) 5.14
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry (2009) 3.33
Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology (2010) 3.08
Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation (2006) 2.34
Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages. Nat Clin Pract Rheumatol (2007) 2.18
Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project. Infection (2015) 2.06
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J (2005) 1.71
Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. J Clin Psychopharmacol (2010) 1.66
Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany. Europace (2013) 1.63
Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke (2006) 1.38
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ (2010) 1.32
Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. Neuro Oncol (2012) 1.26
Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list. Dtsch Arztebl Int (2012) 1.14
Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study. Inflamm Bowel Dis (2010) 1.14
Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis (2010) 1.08
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists. Mov Disord (2009) 1.06
Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. J Child Adolesc Psychopharmacol (2012) 1.01
Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS). Pharmacoepidemiol Drug Saf (2012) 1.01
Comorbidities in ADHD children treated with methylphenidate: a database study. BMC Psychiatry (2013) 1.00
Alcohol consumption, genetic variants in alcohol deydrogenases, and risk of cardiovascular diseases: a prospective study and meta-analysis. PLoS One (2012) 0.98
Regional and temporal variations in coding of hospital diagnoses referring to upper gastrointestinal and oesophageal bleeding in Germany. BMC Health Serv Res (2011) 0.97
Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons. Clin Res Cardiol (2015) 0.96
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma. J Immunother (2009) 0.95
Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study. Sex Transm Dis (2013) 0.94
Systemic antibiotic use among children and adolescents in Germany: a population-based study. Eur J Pediatr (2013) 0.94
Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study. Eur Child Adolesc Psychiatry (2013) 0.93
Hormone replacement therapy use and the risk of stroke. Maturitas (2008) 0.91
Letter by Schmedt and Garbe regarding article, "statins and the risk of cancer after heart transplantation". Circulation (2013) 0.90
Drug-induced agranulocytosis in the Berlin case-control surveillance study. Eur J Clin Pharmacol (2013) 0.89
Citalopram-induced bleeding due to severe thrombocytopenia. Psychosomatics (2009) 0.87
Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans. Europace (2013) 0.85
Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German database. Pharmacoepidemiol Drug Saf (2010) 0.85
Regional variation in caesarean deliveries in Germany and its causes. BMC Pregnancy Childbirth (2013) 0.82
Ramipril-induced liver injury: case report and review of the literature. Am J Hypertens (2013) 0.82
The Risk of Opioid Intoxications or Related Events and the Effect of Alcohol-Related Disorders: A Retrospective Cohort Study in German Patients Treated with High-Potency Opioid Analgesics. Drug Saf (2015) 0.81
Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia. J Clin Psychopharmacol (2013) 0.81
Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol (2014) 0.80
Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug use. Stroke (2013) 0.80
Treatment patterns and characteristics of older antipsychotic users in Germany. Int Clin Psychopharmacol (2016) 0.80
Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database. Eur J Clin Pharmacol (2013) 0.79
Case-control study on analgesics and nephropathy (SAN): protocol. BMC Nephrol (2005) 0.78
Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital. Eur J Clin Pharmacol (2014) 0.78
Twin and sibling studies using health insurance data: the example of attention deficit/hyperactivity disorder (ADHD). PLoS One (2013) 0.78
Treatment of paediatric epilepsy in Germany: antiepileptic drug utilisation in children and adolescents with a focus on new antiepileptic drugs. Epilepsy Res (2012) 0.78
Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study. Am J Hematol (2004) 0.77
Cyclooxygenase inhibitors and cardiovascular risk. JAMA (2007) 0.77
Risks and benefits of celecoxib to prevent colorectal adenomas. N Engl J Med (2006) 0.77
[How many harmed by rofecoxib in Germany?]. Med Klin (Munich) (2006) 0.75
Long-term mortality associated with aprotinin following coronary artery bypass graft surgery. JAMA (2007) 0.75
Risks of postmenopausal hormone replacement. JAMA (2002) 0.75
Utilisation of transdermal fentanyl in Germany from 2004 to 2006. Pharmacoepidemiol Drug Saf (2012) 0.75
3-year prevalence of alcohol-related disorders in German patients treated with high-potency opioids. Pharmacoepidemiol Drug Saf (2012) 0.75
Re: Biphasic fracture risk in diabetes: a population-based study. Bone (2007) 0.75
Erratum to: flupirtine-induced liver injury--seven cases from the Berlin Case-Control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database. Eur J Clin Pharmacol (2015) 0.75
Trends in paediatric macrolide use in five European countries-a population-based study. Eur J Clin Pharmacol (2015) 0.75
Drug-induced kidney injury: A large case series from the Berlin Case-Control Surveillance Study . Clin Nephrol (2017) 0.75
[Diagnostic of ADHD in childhood and adolescence with the K-SADS-PL]. Prax Kinderpsychol Kinderpsychiatr (2013) 0.75
Estimation of background incidence rates of Guillain-Barré syndrome in Germany - a retrospective cohort study with electronic healthcare data. Neuroepidemiology (2014) 0.75